However, limitations include in vivo instability, reliance on biocompatible and robust carriers and restricted application procedures (local and direct)
IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS
Confirm both statements below to access the catalog
Running TB-500 continuously, back to back with no break, isn't something the data supports one way or the other, so the break is the safer default
the study physician attributed the death to pre-existing coronary artery disease unrelated to the drug, but the FDA's Pharmacy Compounding Advisory Committee cited this "unresolved cardiac signal" in December 2024 as a reason to keep the compound off the approved compounding list
Overweight and obesity management (NG246) Appendix P: NICE guideline CG43 [PDF]